'Vaccine safety' presentation slideshows

Vaccinations: Myths vs. Facts

1.11k views • 59 slides

Vaccinations: Myths vs. Facts

1.01k views • 59 slides

Vaccine Adverse Events and Risk Communication In Vaccination

Vaccine Adverse Events and Risk Communication In Vaccination. Najwa Khuri-Bulos MD,FIDSA Jordan University Hospital Amman, Jordan. explaining properly the benefits and risks of a recommended vaccine; addressing public concerns and upcoming or persistent rumours about vaccine safety;

778 views • 57 slides

HPV adolescent vaccination programme August 2019

HPV adolescent vaccination programme August 2019. Aims of Resource. To support healthcare professionals in advising on and delivering the HPV vaccine. To raise awareness on epidemiology of HPV infection. To provide guidance on extension of the vaccination programme to include boys in 2019.

969 views • 47 slides

H1N1 2009

H1N1 2009. dr.faiza shaukat. Statistics of H1N12009 (sep 2009). In US, 183,572 cases and 663 deaths In mexico, 32,025 cases and 358 deaths In china, 14,663 cases and with no deaths In japan, 13, 339 cases and 08 deaths. influenza.

566 views • 46 slides

Fotula Fegaras, PhD Senior Director, Regulatory Affairs Sanofi Pasteur Limited, Toronto, Canada

907 views • 45 slides

Post-exposure Anthrax Vaccination of Pregnant Women

Post-exposure Anthrax Vaccination of Pregnant Women. Lara Misegdes, PhD August 1, 2012. Overview. Vaccines Workgroup Activities Anthrax Vaccine Adsorbed (AVA) Considerations for use of post-exposure AVA in pregnant women ACIP recommendations for use of post-exposure AVA in pregnant women

500 views • 32 slides

Future Challenges for Vaccines

Future Challenges for Vaccines. Many challenges still to be solved Emerging & re-emerging infections Antigenic variation Societal impact of vaccines Opposition to vaccines Safety & risk Poverty related disease.

477 views • 24 slides

ATR on the minutes of last meeting

ATR on the minutes of last meeting. August 24 th & 25 th 2012 Mid-term Meeting of IAPCOI, The Hyatt Regency Hotel , Mumbai. Vipin M. Vashishtha, MD, FIAP Convener, IAPCOI 2011-13 vipinipsita@gmail.com. Am I permitted to click next??. Objectives & Scope of Activities*.

388 views • 24 slides

A European perspective to networking in drug safety, EU-ADR as example

A European perspective to networking in drug safety, EU-ADR as example. Prof. Miriam CJM Sturkenboom and Ir. Martijn Schuemie on behalf of the EU-ADR consortium. Started february 2008.

418 views • 23 slides

Harnessing the Power of Coalitions Idaho Coalition Conference

331 views • 22 slides

The PRISM Network

The PRISM Network. Daniel A. Salmon, PhD, MPH Director of Vaccine Safety National Vaccine Program Office U.S. Department of Health and Human Services. H1N1 Vaccine Safety: Microcosm of the Vaccine Safety Challenge. Response to H1N1 is the largest mass vaccination program in recent history

439 views • 22 slides

Yanomami Social Change

457 views • 21 slides

NVAC Vaccine Safety Working Group

NVAC Vaccine Safety Working Group. Daniel Salmon Vaccine Safety Specialist National Vaccine Program Office Department of Health and Human Services. Working Group Charge 1. Undertake and coordinate a scientific review of the draft ISO research agenda. Advise on:

381 views • 21 slides

The National Vaccine Plan Update: Recent Activities and Next Steps

The National Vaccine Plan Update: Recent Activities and Next Steps. Raymond A. Strikas, MD National Vaccine Program Office Department of Health and Human Services June 7, 2007. Presentation Outline. Process to date March 20, 2007 interagency meeting

329 views • 19 slides

June7, 2007

Subcommittee on Vaccine Safety Subcommittee on Public Communication, Consultation and Participation. June7, 2007. Agenda. Update on ISO reseach agenda development and NVAC role in external review Karen Broder Public input: Lessons learned - Kristin Pope

249 views • 18 slides

An Overview of the Defense Medical Surveillance System The DMSS Project

An Overview of the Defense Medical Surveillance System The DMSS Project. Laura H. Franzke, PhD, MPH National Immunization Program NVAC, June 4 th , 2003. Background.

305 views • 17 slides

A Proposal for a Collaboration with INDEPTH to Engage in Evaluations of Vaccine Safety

PREVENT. A Proposal for a Collaboration with INDEPTH to Engage in Evaluations of Vaccine Safety. Presented by Steven Black, MD on behalf of PREVENT ( PRogram Enhancing Vaccine Epidemiology Networks and Training ). Vaccine Safety in LMIC Current Status.

287 views • 16 slides

Pharmacovigilance: challenges facing WHO

Pharmacovigilance: challenges facing WHO . Shanthi Pal Leader, Medicines Safety Safety and Vigilance, WHO, Geneva. What is pharmacovigilance.

344 views • 15 slides

Update on Large country task team: India

Update on Large country task team: India. Naveen Thacker .

184 views • 8 slides